IN RARE DISEASES
you through every step of your journey taking
your orphan drug to market
TO CARE ABOUT YOU
deeply about the rare circumstances of the
conditions and challenges that are faced.
RIGOUR IN OUR
on our results, and we thrive on that, click
below to find out
EXPERT GLOBAL CONSULTANCY SPECIALIZING IN ACCESS FOR ORPHAN DRUGS
At Partners4Access, we believe patients with rare diseases deserve the right to access the most appropriate treatment. Our vision is ensuring fair access for all key stakeholders. By that, we mean fair access to drugs for rare disease patients, fair value for those that fund treatments, access to the smartest clinical option for the disease expert and a fair return on investment for the orphan drug manufacturer. We work with our biotechnology clients in partnership, to think differently across 5 best practices, and smartly secure access for orphan drugs.
A GLOBAL COMPANY WITH GLOBAL REACH
As a global company, our US team is located on the East Coast, while our EU team has offices in London, Amsterdam and Milan.
We don’t just provide access services, we partner with our clients to help them achieve their PR&MA goals. A large part of that involves us supporting the right strategic and investment decisions.
If you want to increase your success in launching an orphan drug at the right price and access conditions, Partners4Access are the right team for you
We considered Sophie and her team as an extension of our own project group. They were always on hand to advise, support and give us the direction where needed.
Global Project Lead
The choice to go with a specialised orphan consultancy has paid off. The quality of service and advice we’ve been given has made our launch journey much easier to manage. We made the right choice with the P4A team!
European Business Unit Director
P4A have given us credible and objective rationale that we’ve used to support decisions for acquisition of orphan therapies and devices. It’s helped us look at these BD opportunities with open eyes and more importantly, steer our commercial colleagues in the right direction.
Global Access Director, Rare Disease